And let me point out that your observation on ShortMan.com.au is valid, and it is also just as valid as my observation on you looking at MSB from the financials point of view without taking into consideration the progress on the science. Don't feel bad; you are not alone. I observe many people on this forum making that same mistake.
- Forums
- ASX - By Stock
- MSB
- Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure
MSB
mesoblast limited
Add to My Watchlist
0.00%
!
$2.32
Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure, page-90
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
